MARK DAWDY: Open Payments
NPI 1558147538 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 57 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $139 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $183 |
| Lilly USA, LLC | 11 | $173 |
| Novo Nordisk Inc | 12 | $150 |
| ABBVIE INC. | 3 | $71 |
| Antares Pharma, Inc. | 3 | $54 |
| Lundbeck LLC | 2 | $54 |
| PFIZER INC. | 3 | $53 |
| ViiV Healthcare Company | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $36 |
Products named: MOUNJARO, FARXIGA, Ozempic, AIRSUPRA, REXULTI, XYOSTED, UBRELVY, APRETUDE.
Industry payments across MO — which companies pay providers there.
